feed,title,long_url,short_url
Yahoo,Biogen’s pivotal moment: Will the FDA approve the experimental — and controversial — Alzheimer’s-disease drug aducanumab?,https://www.marketwatch.com/story/biogens-pivotal-moment-will-the-fda-approve-the-experimental-and-controversial-alzheimers-disease-drug-aducanumab-11622654675?siteid=yhoof2&yptr=yahoo,https://on.mktw.net/3yZ8eOw
